How are these percentages calculated?These percentages are created by aggregating the total number of claims for the drugs in this class divided by the # of drugs with a specific indication. It is meant to be representative but may not accurately reflect the actual # of prescriptions written to treat specific condition.
Key takeaways
KRAS inhibitors are used to treat certain types of non-small cell lung cancer and colorectal cancer. KRAS inhibitors work by targeting and blocking mutated KRAS proteins, helping to stop the spread of cancer cells. These medications are available in oral forms. Examples include Krazati (adagrasib) and Lumakras (sotorasib).
SOTORASIB treats lung cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
ADAGRASIB treats lung cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Subscribe and save
Get prescription saving tips and more from GoodRx Health. Enter your email to sign up